UGT1A9 and breast carcinoma: It has been shown that resveratrol, as an anticancer drug for breast cancer, can inhibit the development of breast cancer cells by upregulating the expression of NRF2 and UGT1A9, promoting the metabolism of estrogen in the body, and inhibiting the cell damage caused by toxic metabolites produced by estrogen (65).